Etomidate combined with TAPB in ovarian cancer surgery: A controlled study on hemodynamics and immune response.

In 30 seconds

This randomized controlled trial evaluated the effects of etomidate combined with transversus abdominis plane block (TAPB) on hemodynamics and immune response in 80 patients undergoing ovarian cancer surgery. The study found that the combination resulted in significantly lower heart rate and mean arterial pressure during peak intraoperative periods (P<0.001) and improved postoperative immune function compared to total intravenous anesthesia alone.

Key findings

• The research group had significantly lower heart rate and mean arterial pressure during peak intraoperative periods (P<0.001).
• At 24 hours postoperatively, the research group showed significantly reduced levels of high-sensitivity C-reactive protein and tumor necrosis factor-α (all P<0.05).
• Postoperative immune function was better preserved in the research group, with higher CD3+ and CD4+ cell counts (P<0.05).
• The overall incidence of adverse reactions was low and did not differ significantly between groups (4.4% vs 8.9%, P>0.05).

Why it matters

The findings suggest that combining etomidate with TAPB may enhance hemodynamic stability and reduce inflammatory responses during and after ovarian cancer surgery, potentially leading to improved recovery outcomes for patients.